Monash IVF Group Management
Management criteria checks 4/4
Monash IVF Group's CEO is Malik Jainudeen, appointed in Apr 2019, has a tenure of 6.5 years. total yearly compensation is A$495.34K, comprised of 77.4% salary and 22.6% bonuses, including company stock and options. directly owns 0.052% of the company’s shares, worth A$142.73K. The average tenure of the management team and the board of directors is 3.8 years and 10.2 years respectively.
Key information
Malik Jainudeen
Chief executive officer
AU$495.3k
Total compensation
| CEO salary percentage | 77.36% |
| CEO tenure | 6.5yrs |
| CEO ownership | 0.05% |
| Management average tenure | 3.8yrs |
| Board average tenure | 10.2yrs |
Recent management updates
Recent updates
Is Monash IVF Group (ASX:MVF) A Risky Investment?
Aug 22
Benign Growth For Monash IVF Group Limited (ASX:MVF) Underpins Stock's 26% Plummet
Jun 17Monash IVF Group (ASX:MVF) Seems To Use Debt Quite Sensibly
May 20Monash IVF Group Limited's (ASX:MVF) Popularity With Investors Under Threat As Stock Sinks 26%
Apr 29Monash IVF Group (ASX:MVF) Is Increasing Its Dividend To A$0.026
Mar 03Smallcap takeover in niche industry
Monash IVF (ASX: MVF)Monash IVF Group Limited is a leading provider of assisted reproductive services in Australia and Malaysia. With over 50 years of experience, the company has been instrumental inMonash IVF Group's (ASX:MVF) Dividend Will Be A$0.025
Aug 25Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025
Feb 26Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022
Aug 28Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital
Nov 19Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation
Nov 04Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's
Aug 29Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital
May 14Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?
Jun 06Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital
May 25Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value
May 13Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?
Mar 14Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend
Mar 04Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates
Feb 26Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?
Feb 15A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)
Feb 03
We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings
Jan 22Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?
Jan 10Is Monash IVF Group (ASX:MVF) Using Too Much Debt?
Dec 28What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?
Dec 17Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares
Dec 06Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
Nov 24Here's What Monash IVF Group Limited's (ASX:MVF) P/E Ratio Is Telling Us
Jun 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | AU$495k | AU$383k | AU$25m |
| Mar 31 2025 | n/a | n/a | AU$11m |
| Dec 31 2024 | n/a | n/a | -AU$2m |
| Sep 30 2024 | n/a | n/a | -AU$4m |
| Jun 30 2024 | AU$584k | AU$348k | -AU$7m |
| Mar 31 2024 | n/a | n/a | AU$9m |
| Dec 31 2023 | n/a | n/a | AU$24m |
| Sep 30 2023 | n/a | n/a | AU$23m |
| Jun 30 2023 | AU$523k | AU$329k | AU$22m |
| Mar 31 2023 | n/a | n/a | AU$19m |
| Dec 31 2022 | n/a | n/a | AU$17m |
| Sep 30 2022 | n/a | n/a | AU$18m |
| Jun 30 2022 | AU$408k | AU$322k | AU$18m |
| Mar 31 2022 | n/a | n/a | AU$21m |
| Dec 31 2021 | n/a | n/a | AU$23m |
| Sep 30 2021 | n/a | n/a | AU$24m |
| Jun 30 2021 | AU$463k | AU$297k | AU$25m |
| Mar 31 2021 | n/a | n/a | AU$22m |
| Dec 31 2020 | n/a | n/a | AU$18m |
| Sep 30 2020 | n/a | n/a | AU$15m |
| Jun 30 2020 | AU$322k | AU$279k | AU$12m |
| Mar 31 2020 | n/a | n/a | AU$15m |
| Dec 31 2019 | n/a | n/a | AU$18m |
| Sep 30 2019 | n/a | n/a | AU$19m |
| Jun 30 2019 | AU$279k | AU$157k | AU$20m |
Compensation vs Market: Malik's total compensation ($USD327.15K) is below average for companies of similar size in the Australian market ($USD621.95K).
Compensation vs Earnings: Malik's compensation has been consistent with company performance over the past year.
CEO
Malik Jainudeen
Mr. Malik Jainudeen serves as Company Secretary of Monash IVF Group Limited since April 15, 2019 and its Acting Chief Executive Officer since June 12, 2025. Mr. Jainudeen served as Group Chief Financial Of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Acting CEO & Company Secretary | 6.5yrs | AU$495.34k | 0.052% A$ 142.7k | |
| Executive Director | 11.5yrs | AU$385.51k | 0.35% A$ 951.2k | |
| Interim Chief Financial Officer | less than a year | no data | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| Chief Information Officer | 3.8yrs | no data | no data | |
| Chief People & Culture Officer | no data | no data | no data | |
| Chief Governance & Risk Officer | no data | no data | no data | |
| Managing Director of Asia | 2.8yrs | no data | no data |
Experienced Management: MVF's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Director | 11.5yrs | AU$385.51k | 0.35% A$ 951.2k | |
| Independent Non-Executive Director | 11.3yrs | AU$112.00k | 0.090% A$ 245.0k | |
| Independent Non-Executive Chairman | 11.3yrs | AU$200.00k | 0.047% A$ 127.5k | |
| Independent Non-Executive Director | 9yrs | AU$122.00k | 0.024% A$ 65.0k | |
| Independent Non-Executive Director | 5.1yrs | AU$112.00k | 0.0095% A$ 26.0k | |
| Independent Non-Executive Director | 1.7yrs | AU$125.33k | 0.020% A$ 53.9k |
Experienced Board: MVF's board of directors are seasoned and experienced ( 10.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 07:46 |
| End of Day Share Price | 2025/10/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Monash IVF Group Limited is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bradley Watson | Bell Potter |
| Tara Speranza | Bell Potter |
| Martyn Jacobs | Bell Potter |